Abstract
Osteoporosis associated with pregnancy and lactation is a rare condition. The prevalence, etiology and its pathogenesis is unknown. It causes one or more vertebral fractures with severe, prolonged back pain and height loss in affected women. Majority of the cases are seen in the third trimester or just after delivery in primagravid women. In this case report, a 30-year-old woman who had severe pregnancy-induced osteoporosis with 8 vertebral fractures was presented. During last month of her first pregnancy she had moderate back pain. After delivery, the back pain has gotten worse. The radiological examinations have shown that there was 50% in T6, T8 and T10; 30% in L2; 20% in L1 height loss and biconcave vertebral images in L3–5. In the bone mineral density, L2–4 T score was −4.7 and total femoral T score was −3.1. There was no abnormality in the laboratory findings except mild elevation in alkaline phosphates. Although pregnancy-associated osteoporosis is a rare condition, when pain occurs in the last trimester or early postpartum period, it should be considered in differential diagnosis.
References
Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporosis Int 6:345–354
O’Sullivan SM, Grey AB, Singh R, Reid IR (2006) Biphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008–1012
Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol 39:487–490
Ghannam NN, Hammami MM, Bakheet SM, Khan BA (1999) Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation. Calcif Tissue Int 65:23–28
Holmberg-Marttila D, Sievanen H, Tuimala R (1999) Changes in bone mineral density during pregnancy and postpartum: prospective data on five women. Osteoporos Int 10:41–46
Uemura H, Yasui T, Kiyokawa M, Kuwahara A, Kawa H, Matsuzaki T, Maegawa M, Furumoto H, Irahara M (2002) Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. J Endocrinol 174:353–359
Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 1:449–454
Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporosis Int 6:345–354
Foster SA, Foley KA, Meadows ES, Johnston JA, Wang S, Pohl GM, Long SR (2008) Characteristics of patients initiating teriparatide for the treatment of osteoporosis. Osteoporosis Int 19(3):373–377
Semler O, Land C, Schönau E (2007) Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases. Orthopade 36(2):146–151
Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441
Forteo package insert (2002) Forteo (teriparatide) by Eli Lilly and Company. http://www.pi.lilly.com/us/forteo-pi.pdf
Mathis JM, Ortiz AO, Zoarski GH (2002) Vertebroplasty versus kyphoplasty. In: Mathis JM, Deramond H, Belkoff SM (eds) Percutaneous vertebroplasty and kyphoplasty, 2nd edn, Springer, Newyork, pp 145–156
Bayram S, Ozturk C, Sivrioglu K, Aydinli U, Kucukoglu S (2006) Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint bone spine 73(5):564–566
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ofluoglu, O., Ofluoglu, D. A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures. Rheumatol Int 29, 197–201 (2008). https://doi.org/10.1007/s00296-008-0641-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-008-0641-5